In the transgenic AD mouse model, the administration of ECG was found to modulate the profiles of tau, along with prominent suppression of the phosphorylated tau isoforms (i.e., sarkosyl-soluble) [129]. The gene discussed is MAPT; the disease is Alzheimer disease.